Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2024 Aug 27;19(8):e0309109. doi: 10.1371/journal.pone.0309109

Development and testing of a deep learning algorithm to detect lung consolidation among children with pneumonia using hand-held ultrasound

David Kessler 1,*, Meihua Zhu 2, Cynthia R Gregory 2, Courosh Mehanian 2,3,4, Jailyn Avila 5, Nick Avitable 1, Di Coneybeare 1, Devjani Das 1, Almaz Dessie 1, Thomas M Kennedy 1, Joni Rabiner 1, Laurie Malia 1, Lorraine Ng 1, Megan Nye 1, Marc Vindas 1, Peter Weimersheimer 6, Sourabh Kulhare 4, Rachel Millin 4, Kenton Gregory 2, Xinliang Zheng 4, Matthew P Horning 4, Mike Stone 7, Fen Wang 2,8, Christina Lancioni 2
Editor: Tai-Heng Chen9
PMCID: PMC11349203  PMID: 39190686

Abstract

Background and objectives

Severe pneumonia is the leading cause of death among young children worldwide, disproportionately impacting children who lack access to advanced diagnostic imaging. Here our objectives were to develop and test the accuracy of an artificial intelligence algorithm for detecting features of pulmonary consolidation on point-of-care lung ultrasounds among hospitalized children.

Methods

This was a prospective, multicenter center study conducted at academic Emergency Department and Pediatric inpatient or intensive care units between 2018–2020. Pediatric participants from 18 months to 17 years old with suspicion of lower respiratory tract infection were enrolled. Bedside lung ultrasounds were performed using a Philips handheld Lumify C5-2 transducer and standardized protocol to collect video loops from twelve lung zones, and lung features at both the video and frame levels annotated. Data from both affected and unaffected lung fields were split at the participant level into training, tuning, and holdout sets used to train, tune hyperparameters, and test an algorithm for detection of consolidation features. Data collected from adults with lower respiratory tract disease were added to enrich the training set. Algorithm performance at the video level to detect consolidation on lung ultrasound was determined using reference standard diagnosis of positive or negative pneumonia derived from clinical data.

Results

Data from 107 pediatric participants yielded 117 unique exams and contributed 604 positive and 589 negative videos for consolidation that were utilized for the algorithm development process. Overall accuracy for the model for identification and localization of consolidation was 88.5%, with sensitivity 88%, specificity 89%, positive predictive value 89%, and negative predictive value 87%.

Conclusions

Our algorithm demonstrated high accuracy for identification of consolidation features on pediatric chest ultrasound in children with pneumonia. Automated diagnostic support on an ultraportable point-of-care device has important implications for global health, particularly in austere settings.

Introduction

Pneumonia is a leading cause of global pediatric morbidity and mortality, accounting for 14% of all deaths of children under five in 2019 [1]. Deaths from pediatric pneumonia are disproportionately seen in South Asia and Sub-Saharan Africa and represent the single largest infectious cause of death in children worldwide [13]. Consequently, the World Health Organization offers guidelines for hospital admission and empiric antibiotic treatment for presumptive bacterial pneumonia based solely on clinical examination that have led to decreased mortality in resource limited settings [4]. However, chest imaging is still optimal for improving diagnostic accuracy and delivering precision care [5, 6]. Specifically, clinical features such as tachypnea, chest retractions, and hypoxemia, are shared among distinct etiologies of respiratory tract infections in young children, such as viral bronchiolitis and lobar pneumonia, and have different treatment strategies. There is growing concern that antibiotics are overused in the treatment of children presenting with signs and symptoms of lower respiratory tract infection (LRTI), and this may facilitate emergence of antibiotic-resistance [7]. Moreover, lack of access to chest imaging may overlook key severity features of bacterial LRTI, such as the presence of loculated pleural effusions, that require distinct treatment approaches.

Chest radiograph (CXR) is the current gold standard for evaluation of suspected pneumonia or its complications [810]. However, cost, access to technology, lack of timely availability of physicians for image interpretation, and exposure to radiation make CXR a less ideal imaging modality, especially for children in low resource settings. Lack of portable CXR equipment, as well as the inferior quality when available, also limits access to quality chest imaging for children with critical illness who cannot be transported to imaging facilities in low resource settings [11]. Ultrasound is a non-ionizing and less expensive imaging modality that provides comparable or even superior diagnostic accuracy for pneumonia in children [1216]. Several recent meta-analysis demonstrate that lung ultrasound is reliable for identification of pneumonia in both children and adults [1719]. In addition, portability of the equipment, battery-power, quick operation, and ease of serial examinations makes this an ideal technology for austere settings or anywhere that diagnostic imaging at the point-of-care would be beneficial [20]. The primary limitation of ultrasound relates to dependency on operator experience for both acquiring and interpreting the images. However, use of simple standardized imaging protocols to collect data, and artificial intelligence (AI) for image interpretation, offers the potential to close these gaps [21].

Our overall goal is to optimize a pediatric-specific deep-learning algorithm that can be embedded in a point-of-care, hand-held ultrasound device, in order to provide bedside identification of lobar pneumonia, pleural effusion, and empyema among young children presenting with signs and symptoms of LRTI in low resource settings. High sensitivity and specificity, accurate feature localization, and rapid processing time are required attributes of an AI-enabled point-of-care device in order to gain widespread clinical acceptance. Algorithm development is a supervised iterative process of design, training, and fine-tuning to meet these requirements. Our team previously published data on the development and accuracy of a deep-learning algorithm to automatically detect sonographic lung pathology using training data from a swine model, however the model was not transferable to pediatric patient images [22]. In the current study, our primary aim was to develop and test the accuracy of an AI algorithm to detect features of pulmonary consolidation on point-of-care ultrasounds among pediatric patients.

Methods

Study population

Data for design and testing of the algorithm was collected from prospectively enrolled pediatric participants (age 18 months to 17 years old) with suspicion of LRTI or associated complications (e.g., pneumonia, pleural effusion, empyema) between 2018–2020, at two major US pediatric academic centers. Patients were excluded if they were intubated, could not tolerate a lung ultrasound (LUS) due to stress or anxiety of child or parent, or if unable to access chest wall to perform a LUS due to surgical dressing or open wound. To identify potentially eligible patients for study inclusion, the study team screened the current inpatient or Emergency Department census for patients with suspected LRTI and following informed consent (and assent when appropriate) had a study LUS performed. Subsequently, data from the medical records from each participant’s relevant hospitalization were reviewed to obtain demographic and clinical data and to identify individuals diagnosed with and treated for pneumonia. Specifically, data detailing admission and discharge diagnoses, results of any microbiologic testing (respiratory viral panel results were available for 77% of participants), treatment course, performance of pulmonary procedures (eg, chest tube placement; bronchoscopy), and clinical radiologists’ interpretation of chest imaging (available for 89% of participants), were collected. Using this approach, participants with diagnostic studies, clinical course, and documentation supporting a diagnosis of bacterial pneumonia were systematically delineated from participants with other disease processes who were not diagnosed with pneumonia for inclusion in the final training dataset. Adults 18–80 years old with a clinical diagnosis of pneumonia and CXR and/or chest CT evidence of consolidation were enrolled separately, following provision of written informed consent. Adult participants were excluded if they were intubated, had active sepsis, cardiogenic pulmonary edema, known lung cancer, pulmonary embolus, chronic bronchiectasis or cystic fibrosis, or could not tolerate the LUS procedure.

Ethics approval and consent to participate

Written, informed consent was provided by the parent or legal guardian for each participant with assent from children seven years or older in accordance with approval from each sites’ Institutional Review Board. All adult participants also provided written informed consent in accordance with recruitment site Institutional Review Boards.

Scanning protocol and imaging data

All imaging was performed with Philips handheld C5-2 transducers using the Lumify system (Philips, Amsterdam, Netherlands), equipped with an Android tablet (S4, Samsung, Seoul, Korea). LUS exams were collected prospectively during each participant’s hospital visit at the bedside by study investigators, including both research coordinators and clinician-scientists. A standardized protocol that required minimal training was used for bedside image acquisition [23]; prior experience with performance of LUS ranged from none to well-experienced. Bilateral ultrasound scanning of 12 chest-wall areas (zones) was performed on participants in a supine, upright or semi-recumbent position. Each hemi-thorax was divided into 6 zones (upper and lower anterior, upper and lower lateral, upper and lower posterior) using the parasternal, anterior, and posterior axillary lines as anatomical landmarks (see S1 Fig). The Lumify system software “Lung” preset was selected with a default 12 cm image depth and gain of 36. Depending on the body habitus and age of the child, the depth could be adjusted by the operator to between 6 and 12 cm. Three-second video loops were acquired in each zone while holding the probe still in the sagittal plane (long axis) with the transducer marker pointed towards the participant’s head. The acquired video loops were exported as .mp4 video files.

To develop the algorithm, positive consolidation videos were curated from participants enrolled with suspicion of pneumonia or associated complications. The clinical diagnosis of pneumonia was corroborated by the participant’s discharge diagnosis supplemented with either CXR or CT scan findings (89% of participants) and respiratory viral panel results (77% of participants). Negative (no consolidation) videos were taken from the unaffected lung zones of participants with pneumonia as well as from participants without a diagnosis of pneumonia. Videos previously collected from adults with lower respiratory tract disease were added to enrich algorithm training. Clinical data to confirm the diagnosis of pneumonia was derived from a chart review conducted by research coordinators asynchronously from LUS image acquisition.

Annotation

The annotation workflow (Fig 1), was a multi-step process with several quality control (QC) steps. Each participant’s clinical data and lung ultrasound videos were reviewed by two physicians to confirm their merit for annotation. Annotation occurred at two levels: (i) at the entire video level for the lung features present; and (ii) at the frame level for localization of the lung features within each frame.

Fig 1. Lung ultrasound annotation workflow.

Fig 1

Multi-step workflow for review and annotation of lung ultrasound videos is depicted. QC = quality control, VA = video annotator, FA = frame annotator.

Video annotation

The Lumify was operated at 20 frames/second. Every frame of every video containing relevant lung features was annotated. Video annotators (two physician LUS experts) labeled videos according to what features they exhibited using a standardized digital annotation platform. Labels included the normal features of non-diseased lungs (pleural line, A-lines) as well as potentially pathologic features of diseased lungs (consolidation, pleural effusion, sub-pleural changes, atelectasis, B-line, or merged B-line). Video annotators could reject a video for quality issues or exclusion criteria that may have been missed at the initial QC step. If the two annotators disagreed on the feature content, the video was passed to a third video annotator to arbitrate the video labeling. The arbitration of disagreements between video annotators was an iterative process. If a video was accepted, and if all annotators agreed on the feature content of the video, it was passed to frame annotators. For this study, only videos that contained consolidation confirmed by two video annotators were included in the positive consolidation set. The presence of air bronchograms was used to distinguish between consolidation resulting from infection (pneumonia), and suspected atelectasis, with the latter feature excluded from model training.

Frame annotation

Frame annotators had educational backgrounds in anatomy and physiology and were trained by physician LUS experts to recognize the specific LUS features of interest. Frame annotators assessed every frame of a video for lung features indicated by the video annotators and marked them with bounding boxes. Frames without any of the pre-defined pathologic features were included as examples of non-diseased (normal) areas of the lung. Frame annotation and bounding boxes were reviewed first by a video annotator and then verified by the algorithm team to ensure they were of sufficient quality and that the annotations were consistent and suitable for machine learning. Frame annotation was the most-labor intensive step of the process and was necessary to enable explainable outputs from the algorithm that localize features, distinguish between diseased and non-diseased tissues, and inspire clinician confidence in the algorithm.

Machine learning protocol

Data distribution

The data were split into training, tuning, and holdout sets at the participant level. The training set was used to learn model weights, the tuning set was used to set model hyperparameters, and the holdout set was used to evaluate algorithm performance (see Table 1).

Table 1. Source and utilization of ultrasound data.
Subset Hospitals Participants Exams –Videos +Videos
Training 1 56 63 372 323
Tuning 2 24 24 71 122
Holdout 2 27 30 146 159
Adult training 6 44 102 843 498

–Videos = consolidation feature not present; +Videos = consolidation feature present

Algorithm architecture

The algorithm’s architecture was designed to be capable of both video-level analysis and frame level localization. The primary goal was to identify whether a video was positive or negative for consolidation; additional goals were to pinpoint the exact frames within those videos, and the locations within those frames, where the consolidation was present. To achieve these dual requirements, a cascade architecture was adopted, meaning that the algorithm passed the input video through multiple processing steps.

The first processing step was to classify each frame of the input video as either positive or negative for consolidation. The algorithm did this by employing a frame classifier that has a binary yes/no output to assess every frame within the video, categorizing them as either positive or negative for the presence of a consolidation. The convolutional neural network (CNN) architecture for the frame classifier was a VGG-like network trained on all frames in the training subset (using the frame labels, but ignoring bounding boxes that were drawn by annotators around the specific features of the consolidation) [24].

The second step was to classify the whole video as either exhibiting consolidation or not. Video classification was determined by applying a threshold to the number of positively-classified frames. For videos that were classified as positive in the second step, the algorithm executed a third processing step in which frames that were classified as positive were passed to an object detector to localize the consolidation with a bounding box. This third object detection step employed a single-shot architecture using a MobileNet V3 CNN as the base network [25, 26]. It was trained with the frame-level bounding boxes drawn by annotators around the consolidation in the training set. Once the model was trained, the total processing time of the three-step cascade on the ultrasound transducer’s native tablet device was under ten seconds per video.

The net effect of the automated processing is to determine if a lung ultrasound video (taken from one of the different lung zones) exhibits a consolidation or not. When a video is labeled as showing a consolidation, the tablet replays the video with boxes drawn around the areas of consolidation that the algorithm identified in each frame. These boxes help the user to understand why the algorithm made its decision about a video classification. This creates transparency and builds trust in the automated algorithm. Users can then use their own medical expertise to confirm if the algorithm was accurate and make medical decisions.

Sample size and analysis plan

The main study outcome was test performance of the algorithm at the video level to detect consolidation on lung ultrasound. Reference standard diagnosis of positive or negative pneumonia was derived from chart data confirming a clinical diagnosis of pneumonia along with consistent findings on radiologic imaging. Deep learning algorithms require a sufficient number of training samples to learn a viable model, but it is not always possible to predict in advance how many samples will be needed. Our goal was to achieve at least 90% accuracy which was considered on par with CXR as the current standard of care diagnostic imaging test for pneumonia. Model localization performance was analyzed using Intersection-over-Union (IoU) measuring the amount of overlap between the algorithm detected bounding boxes and expert-annotated bounding boxes outlining areas of consolidation. Diagnostic performance of the model was analyzed using Pearson Chi Square 2x2 contingency tables to calculate test characteristics (sensitivity, specificity, positive and negative predictive value) of the model in identifying videos with features of pulmonary consolidation as compared to our reference standard.

Results

Participant recruitment and characteristics

107 pediatric participants were enrolled, yielding 1,193 pediatric videos (approximately 10 videos per participant) for the algorithm development process. From these 1193 videos, 159 positive consolidation videos and 146 negative videos were utilized for algorithm testing (see Table 1). Low quality videos were excluded, with the main issues compromising quality related to poor transducer contact, bad transducer angle, transducer motion, or other organs obstructing visualization of the lungs. Median age of participants in the pediatric testing set was 6 years old (range 18 months to 17 years old, IQR = 61.2 months). LUS data from 44 adults hospitalized with pneumonia was added to the training data set. The addition of adult data served the dual purposes of increasing the amount of data (as deep learning networks require large amounts of training data) and adding more diversity. Specifically, the addition of adult data was felt to enhance representation of data from pediatric participants between 14–18 years old in the training data set. Table 2 shows additional characteristics of the pediatric population included in the algorithm testing.

Table 2. Population characteristics of pediatric participants contributing videos to algorithm development.

Median age in months, (IQR) 72 (61.2)
Median weight in kilograms, (IQR) 24.1 (19.35)
Positive respiratory pathogen test, n (%) 57 (53%)
Influenza A 4
Influenza B 6
Human MPV 12
Rhinovirus/Enterovirus 20
Adenovirus 3
Parainfluenza 4
Respiratory syncytial virus 6
Mycoplasma pneumoniae 6
Bordetella Parapertussis 1
Coronavirus 2
Multiple pathogens* 6
Negative respiratory pathogen test, n 28 (26%)
No respiratory pathogen testing completed, n 22 (21%)

*Specific frequency of each respiratory pathogen already displayed in table

Table 3 summarizes the performance metrics of the pediatric consolidation algorithm described above. Video level sensitivity was 88% and specificity was 89% for detecting consolidation. Average localization accuracy, as measured by the IoU between algorithm LUS detected and consolidation localized by expert assessment was 0.62.

Table 3. Two by two table illustrating sensitivity, specificity, positive predictive value, and negative predictive value of the pediatric consolidation feature algorithm to detect pneumonia.

Reference standard (ground truth) Sensitivity
(95% CI)
88%
(82–93%)
Positive pneumonia Negative pneumonia Specificity
(95% CI)
89%
(83–94%)

Ultrasound Algorithm
Positive consolidation 140 16 Positive Predictive Value
(95% CI)
89%
(85–93%)
Negative consolidation 19 130 Negative Predictive Value
(95% CI)
87%
(82–91%)

CI = confidence interval

False negatives and positives

Of 159 positive videos, 19 were falsely classified by the algorithm as negative for consolidation. Over three quarters of the missed consolidations were due to the algorithm failing to detect transiently visible consolidations that moved behind a rib shadow intermittently as the participant respires. The remaining missed consolidations were smaller in size (<5 mm), at the boundary between actionable consolidations and clinically insignificant ones [16].

Of 146 negative videos, 16 were falsely classified by the algorithm as positive for a consolidation. Over half of the false positives (9/16) were triggered by abnormal pleural lines that were either thickened, irregular, or interrupted. The remaining false positives were triggered by atelectasis or B-lines emanating from a thickened or irregular pleural line.

An example of the algorithm output overlying the consolidation localized by conventional CXR, can be seen in Fig 2.

Fig 2. Sample algorithm output for consolidation and normal pleural line features overlaid on expert-defined bounding boxes for the same features.

Fig 2

Red and yellow rectangles indicate the algorithm output for detecting consolidation and normal pleural line features, respectively, with the numbers above the rectangles representing the algorithm output confidence scores. Purple and green rectangles indicate the expert annotated bounding boxes for consolidation and normal pleural line features, respectively.

Discussion

Severe pneumonia remains the leading cause of death among young children worldwide [1]. Current international guidelines that base diagnosis of pneumonia on history and clinical exam are intended to identify young children who would benefit from empiric antibiotics and do not offer high diagnostic accuracy [20, 27]. This inaccuracy places young children at risk for a missed diagnosis of bacterial pneumonia and its complications such as empyema, while also increasing exposure to inappropriate antibiotics among children with viral upper-respiratory tract infections and/or bronchiolitis that mimic the clinical presentation of bacterial pneumonia [6]. LUS has emerged as a highly accurate imaging modality to identify pulmonary consolidation as well as complications of severe pneumonia, such as pleural effusions and empyema, in well-resourced settings [1216, 20]. However, in low resource settings where the need for improved diagnostics is most urgent, equipment to perform lung ultrasound (and even conventional CXR) and the expertise to interpret imaging are rarely available. To address this need, we developed and tested a point-of-care algorithm that detects LUS features of pulmonary consolidation in children. Our results demonstrated promising diagnostic accuracy for this feature interpretation algorithm, with performance near expert level of 90% sensitivity and specificity. We also demonstrated a strong IoU (0.62) that corresponds to roughly 79% linear dimension overlap between the algorithm’s feature detection and expert annotation. This provides a powerful proof-of-concept that an AI algorithm applied to point-of-care LUS videos can be deployed to improve diagnosis of pneumonia in children, and may be particularly impactful in low resource settings.

There has been a tremendous expansion of research into the development and testing of AI to diagnose lung features [21, 22, 28, 29]. However, ours is one of the only studies validated on a point-of-care device specifically detecting features of pediatric pneumonia across entire videos. Correa et al. developed a model for analysis of pediatric LUS videos based on a neural network classifying small feature vectors that are distilled from a few frames of each video [30]. They achieved a sensitivity of 90.9% and specificity of 100% to correctly identify regions of ultrasound that contained a consolidation. However, the combined design and test dataset was very small: the total number of participants was 21, and the total number of video frames was 60. The small dataset precluded the ability to compute reliable patient-level performance metrics—which is what matters most for clinical applications. Furthermore, the images were acquired using an Ultrasonix device, (BK Medical, Vancouver, British Columbia, Canada), which is a larger and more expensive device, thus limiting generalizability to low-resource settings where such equipment would not be available. In contrast, our algorithm was trained on videos acquired on an ultraportable device by minimally trained research personnel following a simple standard protocol, making our findings more transferable to austere environments and a variety of operators. Importantly, all images were acquired point-of-care at the bedside by research team members using a study-specific standardized operating procedure; images were not acquired by radiologists or professional sonographers. In addition, rather than simply detecting a region of interest, our algorithm directly identified consolidations making it more useful for novice operators. Nti et al. explored the use of AI software to help guide novices in identifying lung features acquired on a Zonare machine (Zs3, Mindray North America, Mahwah, NJ, USA) and found it helped improve novice recognition and diagnosis of abnormal features [31]. They did not employ an ultraportable device, however their pilot study demonstrated the potential for scalability of software that is agnostic to specific machines or companies.

Limitations

Our accuracy fell short of our 90% goal which may be attributable to the relatively small training set size. One of the biggest challenges for our algorithm was accurately diagnosing transient features. This is mainly due to the current version of the video classifier being frame-based and not accounting for temporal dynamics, (i.e., a consolidation that disappears behind the rib with each respiratory cycle). Future iterations of the algorithm will incorporate methods that model temporal dynamics and should be able to detect a better portion of these false negatives. The algorithm was developed, trained, and tested only on images with consolidations caused by pneumonia. In addition, there are other diseases that can lead to alveolar injury and filling seen on LUS. Therefore, it is not clear how well this algorithm will be able to distinguish pneumonia from other causes of consolidation artifacts on LUS (e.g., atelectasis). Given the higher prevalence in adult populations of these other illnesses, the addition of adult training data is a potential contributing factor to this as well. Our study did not test participants systematically for viral or bacterial pathogens, and thus we were unable to probe relationships between the causative organism and findings on LUS. Our study design also did not allow us to determine if our LUS imaging protocol and algorithm could identify small consolidations (< 5mm), or the relationship between specific features of consolidations (such as dimensions) and etiology, as has been suggested by a prior study [32]. Since pneumonia is a common cause of lower respiratory infection in low-resource outpatient settings, the algorithm’s specificity may be adequate for this patient population, but limited in other settings. Finally, the algorithm was highly unpredictable in discerning ambiguous or borderline lung features, for example small consolidations or irregular pleural lines. These borderline features can also be difficult for experts to classify and there remains ambiguity as to the clinical significance for borderline features, such as sub-centimeter consolidations [3335]. Ambiguous features are a general problem in the application of AI to medicine, one which begs for a principled and robust approach that will alert the user when the algorithm is unsure of its findings. Future directions include exploring the use of multiclass networks and networks that provide an auxiliary output indicating the uncertainty of their findings as potential avenues for ameliorating the impact of ambiguous patterns. Wearable technology may also provide the opportunity to acquire continuous serial imaging data over an entire disease [36].

Conclusion

A deep learning algorithm developed from images acquired on an ultraportable device demonstrates high accuracy, sensitivity, and specificity, for identification of consolidation features on pediatric chest ultrasound among children with pneumonia. The capacity to deploy automated and accurate diagnostic support on an ultraportable point-of-care device has important implications for global health, especially in low-resource or austere settings.

Supporting information

S1 Fig. Scanning zones for pediatric lung ultrasound.

Lung image acquisition areas. Anterior scan areas: right hemithorax–areas 1, 2, 3, and 4; left hemithorax–areas 5, 6, 7, and 8. Posterior scan areas: right hemithorax–areas 9 and 10; left hemithorax–areas 11 and 12. (Created with BioRender.com).

(PDF)

pone.0309109.s001.pdf (338.8KB, pdf)

Acknowledgments

The authors thank Erin Merrifield (OHSU) for her help with participant enrollment, ultrasound image acquisition, and clinical data organization. They also thank the OHSU Center for Regenerative Medicine staff members Amber Halse, Andrew Jones, Jack Lazar, Yuan Zhang, Annie Cao, and Katelyn Hostetler for their frame annotation of ultrasound images.

Data Availability

the data underlying the findings described within this manuscript are freely available in a public repository: (https://dataverse.harvard.edu/dataset.xhtml?persistentId=doi:10.7910/DVN/3HP1RD).

Funding Statement

This work was supported via a Defense Advanced Research Projects Agency (DARPA) award “Hand-Held Convolutional-Neural-Network based Field Diagnostic Ultrasound” Technology Investment Agreement No. HR0011-17-3-0001 to Inventive Government Solutions, LLC and subcontracted to OHSU. Co-funding was also provided by the Global Good Fund. There was no additional external funding received for this study. The funders provided support in the form of salaries for authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section”.

References

  • 1.World Health Organization, “Pneumonia in Children.” https://www.who.int/en/news-room/fact-sheets/detail/pneumonia. Accessed June 23, 2023.
  • 2.Krishnan A, Amarchand R, Gupta V, et al. Epidemiology of acute respiratory infections in children—preliminary results of a cohort in a rural north Indian community. BMC Infect Dis. 2015. Oct 26;15:462. doi: 10.1186/s12879-015-1188-1 ; PMCID: PMC4624162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Madhi SA, De Wals P, Grijalva CG, et al. The burden of childhood pneumonia in the developed world: a review of the literature. Pediatr Infect Dis J. 2013;32:E119–E127. doi: 10.1097/INF.0b013e3182784b26 [DOI] [PubMed] [Google Scholar]
  • 4.Exploratory meeting to review new evidence for Integrated Management of Childhood Illness danger signs, Geneva, Switzerland, 4–5 September 2018. Geneva: World Health Organization; 2019. (WHO/MCA/19.02). License: CC BY-NC-SA 3.0 IGO. Available from: https://apps.who.int/iris/handle/10665/326100 Accessed August 22, 2023. [Google Scholar]
  • 5.World Health Organization, Recommendations for Management of Common Childhood Conditions: Evidence for Technical Update of Pocket Book Recommendations: Newborn Conditions, Dysentery, Pneumonia, Oxygen Use and Delivery, Common Causes of Fever, Severe Acute Malnutrition and Supportive Care. Geneva; 2012. Available from: https://www.ncbi.nlm.nih.gov/books/NBK138333/ Accessed September 27, 2022. [PubMed] [Google Scholar]
  • 6.Jankauskaite L, Oostenbrink R. Childhood lower respiratory tract infections: more evidence to do less. Lancet. 2021. Oct 16;398(10309):1383–1384. doi: 10.1016/S0140-6736(21)01955-3 Epub 2021 Sep 22. . [DOI] [PubMed] [Google Scholar]
  • 7.Sazawal S, Black RE. Effect of pneumonia case management on mortality in neonates, infants, and preschool children: a meta-analysis of community-based trials. Lancet Infect Dis 2003; 3: 547–56. doi: 10.1016/s1473-3099(03)00737-0 [DOI] [PubMed] [Google Scholar]
  • 8.Htun TP, Sun Y, Chua HL, et al. Clinical features for diagnosis of pneumonia among adults in primary care setting: A systematic and meta-review. Sci Rep. 2019. May 20;9(1):7600. doi: 10.1038/s41598-019-44145-y ; PMCID: PMC6527561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Shah SN, Bachur RG, Simel DL, et al. Does This Child Have Pneumonia?: The Rational Clinical Examination Systematic Review. JAMA. 2017. Aug 1;318(5):462–471. doi: 10.1001/jama.2017.9039 Erratum in: JAMA. 2017 Oct 3;318(13):1284. . [DOI] [PubMed] [Google Scholar]
  • 10.Lynch T, Bialy L, Kellner JD, et al. A systematic review on the diagnosis of pediatric bacterial pneumonia: when gold is bronze. PLoS One. 2010. Aug 6;5(8):e11989. doi: 10.1371/journal.pone.0011989 ; PMCID: PMC2917358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Jin M X, Gilotra K, Young A, et al. (September 15, 2022) Call to Action: Creating Resources for Radiology Technologists to Capture Higher Quality Portable Chest X-rays. Cureus 14(9): e29197. doi: 10.7759/cureus.29197 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Balk DS, Lee C, Schafer J, et al. Lung ultrasound compared to chest X-ray for diagnosis of pediatric pneumonia: A meta-analysis. Pediatr Pulmonol. 2018. Aug;53(8):1130–1139. doi: 10.1002/ppul.24020 Epub 2018 Apr 26. . [DOI] [PubMed] [Google Scholar]
  • 13.Biagi C, Pierantoni L, Baldazzi M, et al. Lung ultrasound for the diagnosis of pneumonia in children with acute bronchiolitis. BMC Pulm Med. 2018. Dec 7;18(1):191. doi: 10.1186/s12890-018-0750-1 ; PMCID: PMC6286612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Pereda MA, Chavez MA, Hooper-Miele CC, et al. Lung ultrasound for the diagnosis of pneumonia in children: a meta-analysis. Pediatrics. 2015. Apr;135(4):714–22. doi: 10.1542/peds.2014-2833 Epub 2015 Mar 16. . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Lissaman C, Kanjanauptom P, Ong C, et al. Prospective observational study of point-of-care ultrasound for diagnosing pneumonia. Arch Dis Child. 2019. Jan;104(1):12–18. doi: 10.1136/archdischild-2017-314496 Epub 2018 Jun 7. . [DOI] [PubMed] [Google Scholar]
  • 16.Jones BP, Tay ET, Elikashvili I, et al. Feasibility and Safety of Substituting Lung Ultrasonography for Chest Radiography When Diagnosing Pneumonia in Children: A Randomized Controlled Trial. Chest. 2016. Jul;150(1):131–8. doi: 10.1016/j.chest.2016.02.643 Epub 2016 Feb 26. . [DOI] [PubMed] [Google Scholar]
  • 17.Yan JH, Yu N, Wang YH, Gao YB, Pan L. Lung ultrasound vs chest radiography in the diagnosis of children pneumonia: Systematic evidence. Medicine (Baltimore). 2020. Dec 11;99(50):e23671. doi: 10.1097/MD.0000000000023671 ; PMCID: PMC7738074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Lu Xiaoxuea,*; Yanpingb Jin,*; Yingc Li; Weng Liangd; Huie Li. Diagnostic accuracy of lung ultrasonography in childhood pneumonia: a meta-analysis. European Journal of Emergency Medicine 29(2):p 105–117, April 2022. | doi: 10.1097/MEJ.0000000000000883 [DOI] [PubMed] [Google Scholar]
  • 19.Sistani SS, Parooie F. Diagnostic Performance of Ultrasonography in Patients With Pneumonia: An Updated Comparative Systematic Review and Meta-analysis. Journal of Diagnostic Medical Sonography. 2021;37(4):371–381. doi: 10.1177/8756479321992348 [DOI] [Google Scholar]
  • 20.Ellington LE, Gilman RH, Chavez MA, et al. Lung ultrasound as a diagnostic tool for radiographically-confirmed pneumonia in low resource settings. Respir Med. 2017. Jul;128:57–64. doi: 10.1016/j.rmed.2017.05.007 Epub 2017 May 15. ; PMCID: PMC5480773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Jia LL, Zhao JX, Pan NN, et al. Artificial intelligence model on chest imaging to diagnose COVID-19 and other pneumonias: A systematic review and meta-analysis. Eur J Radiol Open. 2022;9:100438. doi: 10.1016/j.ejro.2022.100438 Epub 2022 Aug 18. ; PMCID: PMC9385733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Kulhare S, Zheng X, Mehanian C, et al. (2018). Ultrasound-based detection of lung abnormalities using single shot detection convolutional neural networks. In Simulation, image processing, and ultrasound systems for assisted diagnosis and navigation (pp. 65–73). Springer, Cham. [Google Scholar]
  • 23.Volpicelli G, Elbarbar M, Blavais M, et al. , International evidence-based recommendations for point-of-care lung ultrasound, Intensive Care Medicine, vol. 38, 2012, pp. 577–591. doi: 10.1007/s00134-012-2513-4 [DOI] [PubMed] [Google Scholar]
  • 24.Simonyan K, Zisserman A, Very deep convolutional neural networks for large-scale image recognition, arXiv preprint arXiv:1409.1556 (2014). [Google Scholar]
  • 25.Liu W, Anguelov D, Erhan D, et al. SSD: single shot multibox detector, IEEE ECCV (2016) 21–37 [Google Scholar]
  • 26.Howard A, Sandler M, Chu G, et al. Searching for MobileNetV3, IEEE ICCV (2019) 1314–1324. [Google Scholar]
  • 27.Chavez MA, Naithani N, Gilman RH, et al. Agreement Between the World Health Organization Algorithm and Lung Consolidation Identified Using Point-of-Care Ultrasound for the Diagnosis of Childhood Pneumonia by General Practitioners. Lung. 2015. Aug;193(4):531–8. doi: 10.1007/s00408-015-9730-x Epub 2015 Apr 29. . [DOI] [PubMed] [Google Scholar]
  • 28.Moore CL, Wang J, Battisti AJ, et al. Interobserver Agreement and Correlation of an Automated Algorithm for B-Line Identification and Quantification with Expert Sonologist Review in a Handheld Ultrasound Device. J Ultrasound Med 2021. doi: 10.1002/jum.15935 [published Online First: 2021/12/30] [DOI] [PubMed] [Google Scholar]
  • 29.Mondal MRH, Bharati S, Podder P. Diagnosis of COVID-19 Using Machine Learning and Deep Learning: A Review. Curr Med Imaging. 2021;17(12):1403–1418. doi: 10.2174/1573405617666210713113439 . [DOI] [PubMed] [Google Scholar]
  • 30.Correa M, Zimic M, Barrientos F, et al. Automatic classification of pediatric pneumonia based on lung ultrasound pattern recognition. PLoS One. 2018. Dec 5;13(12):e0206410. doi: 10.1371/journal.pone.0206410 ; PMCID: PMC6281243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Nti B, Lehmann AS, Haddad A, et al. Artificial Intelligence-Augmented Pediatric Lung POCUS: A Pilot Study of Novice Learners. J Ultrasound Med. 2022. Apr 15. doi: 10.1002/jum.15992 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Berce V, Tomazin M, Gorenjak M, Berce T, Lovrenčič B. The Usefulness of Lung Ultrasound for the Aetiological Diagnosis of Community-Acquired Pneumonia in Children. Sci Rep. 2019. Nov 29;9(1):17957. doi: 10.1038/s41598-019-54499-y ; PMCID: PMC6884636. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Gravel CA, Neuman MI, Monuteaux MC, et al. Significance of Sonographic Subcentimeter, Subpleural Consolidations in Pediatric Patients Evaluated for Pneumonia. J Pediatr. 2022. Apr;243:193–199.e2. doi: 10.1016/j.jpeds.2021.12.052 [DOI] [PubMed] [Google Scholar]
  • 34.Tsung JW, Kessler DO, Shah VP. Prospective application of clinician-performed lung ultrasonography during the 2009 H1N1 influenza a pandemic: distinguishing viral from bacterial pneumonia. Crit Ultrasound J. 2012;4:16 doi: 10.1186/2036-7902-4-16 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Iorio G, Capasso M, Prisco S, et al. Lung Ultrasound Findings Undetectable by Chest Radiography in Children with Community-Acquired Pneumonia. Ultrasound Med Biol. 2018. Aug;44(8):1687–1693. doi: 10.1016/j.ultrasmedbio.2018.04.007 . [DOI] [PubMed] [Google Scholar]
  • 36.Elloian J, Jadwiszczak J, Arslan V, et al. Flexible ultrasound transceiver array for non-invasive surface-conformable imaging enabled by geometric phase correction. Scientific reports. 2022. Sep 28;12(1):1–2. [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Tai-Heng Chen

15 Feb 2024

PONE-D-23-38634Development and testing of a deep learning algorithm to detect pediatric pneumonia on a portable ultrasound devicePLOS ONE

Dear Dr. Kessler,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Mar 31 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Tai-Heng Chen, M.D., Ph.D.

Academic Editor

PLOS ONE

Journal requirements:

1. When submitting your revision, we need you to address these additional requirements.

Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please note that PLOS ONE has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, all author-generated code must be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse.

3. Thank you for stating in your Funding Statement: 

This work was supported via a Defense Advanced Research Projects Agency award “Hand-Held Convolutional-Neural-Network based Field Diagnostic Ultrasound” Technology Investment Agreement No. HR0011-17-3-0001 to Inventive Government Solutions, LLC and subcontracted to OHSU.  Co-funding was provided by the Global Good Fund, under auspices of the Bill and Melinda Gates Foundation Trust, awarded to Intellectual Ventures Laboratory. Dr. Kenton Gregory received salary support thru Intellectual Ventures Laboratory, a company that may have a commercial interest in the results of this research and technology.  

Please provide an amended statement that declares all the funding or sources of support (whether external or internal to your organization) received during this study, as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now.  Please also include the statement “There was no additional external funding received for this study.” in your updated Funding Statement. 

Please include your amended Funding Statement within your cover letter. We will change the online submission form on your behalf.

4. Thank you for stating the following in the Competing Interests section: 

I have read the journal's policy and the authors of this manuscript have the following competing interests: Drs. Kenton and Cynthia Gregory received salary support thru Intellectual Ventures Laboratory, a company that may have a commercial interest in the results of this research and technology.  This potential conflict for Drs. Kenton and Cynthia Gregory has been reviewed and managed by OHSU.

  

We note that one or more of the authors are employed by a commercial company.

a. Please provide an amended Funding Statement declaring this commercial affiliation, as well as a statement regarding the Role of Funders in your study. If the funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials, please review your statements relating to the author contributions, and ensure you have specifically and accurately indicated the role(s) that these authors had in your study. You can update author roles in the Author Contributions section of the online submission form.

Please also include the following statement within your amended Funding Statement. 

“The funder provided support in the form of salaries for authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.”

If your commercial affiliation did play a role in your study, please state and explain this role within your updated Funding Statement. 

b. Please also provide an updated Competing Interests Statement declaring this commercial affiliation along with any other relevant declarations relating to employment, consultancy, patents, products in development, or marketed products, etc.  

Within your Competing Interests Statement, please confirm that this commercial affiliation does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to  PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests) . If this adherence statement is not accurate and  there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared.

Please include both an updated Funding Statement and Competing Interests Statement in your cover letter. We will change the online submission form on your behalf.

5. In the online submission form, you indicated that the data underlying the results presented in the study are available upon request from the corresponding author.

All PLOS journals now require all data underlying the findings described in their manuscript to be freely available to other researchers, either a. In a public repository, b. Within the manuscript itself, or c. Uploaded as supplementary information.

This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If your data cannot be made publicly available for ethical or legal reasons (e.g., public availability would compromise patient privacy), please explain your reasons on resubmission and your exemption request will be escalated for approval. 

6. One of the noted authors is a group or consortium. In addition to naming the author group, please list the individual authors and affiliations within this group in the acknowledgments section of your manuscript. Please also indicate clearly a lead author for this group along with a contact email address.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thank you very much for the opportunity to review the manuscript. I found it very well-written, clearly written, enjoyable to read, and worthy of publication. I share the vision the authors have put forth and believe this is a very important work to improve access to imaging. The results are also of great interest to the scientific community.

I had a few minor comments that the authors may consider when submitting any revisions.

-Line 58, I agree CXR is the current standard of care, but in meta-analysis lung ultrasound seems to perform better. Perhaps a distinction could be made in this regard.

-The authors mention the use of adult imaging. I understand the focus of your manuscript is on pediatric patients. If possible, I still think the adults you scanned should ideally be included in the description of the study population section. Were adults enrolled with the same criteria?

-Can you please consider explaining the rationale for adding adult images in a little more detail? You state it is to “enrich” the data but I think it may be beneficial to explain what about the adult data enriches the AI – for example more studies to train the AI, more generalizability etc.? Your manuscript specifically focuses on pediatric groups but of course this could also be used in adults. I think it could also be an interesting area of discussion in any differences between the adult and pediatric populations as a future consideration but I wouldn’t want this to distract from the focus of your manuscript which I feel is already well written as it is. Perhaps a few sentences could be included commenting on this in the discussion if you feel it could be beneficial. Otherwise, I also understand if you want to keep the focus of the manuscript on children and not comment further.

-If you had 117 unique exams, multiplied by 12 that would be 1,404 video clips. You report using 1,193 video clips. I assume the 211 difference related to clips that were not of adequate quality? What were some of the quality issues that made a clip not usable? For example, were their problems with motion artifact or not enough gel? If you could provide exact data regarding clips were rejected that would be interesting if you happened to record it, but I think even just some generalized qualitative description of things that affected quality would be helpful.

-Were the images acquired point-of-care at the bedside or in an ultrasound suite or a combination? Were the exams performed by physicians or by sonographers or a combination? Readers may also benefit from a little more information about how the people acquiring the images were trained and what their background was prior to the study. In the discussion you describe “minimally trained research personnel” line 306. I assume the multi-center nature of your study may have individuals with a variety of backgrounds acquiring the imaging? More information about those scanning and how many people scanned would be helpful/interesting if possible.

-How many frames per second does Lumify record? Was every single frame labeled?

-I found the discussion section enlightening, relevant, and useful. I particularly appreciate the discussion on the challenges of AI in relation to ambiguous cases and feel the authors have provided a very useful discussion of the promise of this work and areas of further optimization going forward.

-My copy of Figure 1 and Figure 2 are grainy. I’m not sure if this is related to the reviewer quality shared with me but please double check the image submitted before publication to ensure the image and text is as high resolution possible.

-Again, I commend the authors on this work. I believe they have shown a very strong proof of concept for this approach and their work merits publication.

Reviewer #2: The paper subject is very interesting, as lung ultrasound is a reliable method for lung assessment in children respiratory pathology and the study background accordingly to premises.

There are limitations that must be acknowledge, like retro scapular regions, difficult to evaluate

Please insert data to clarify the following issues:

-pneumonia diagnosis criteria used for this study

-consolidations might be present even in viral pneumonia, please state the relation with etiology

-no clear data on relation between dimensions and etiology, even if several paper suggests the relation( eg.Kharasch S, Duggan NM, Cohen AR, Shokoohi H. Lung Ultrasound in Children with Respiratory Tract Infections: Viral, Bacterial or COVID-19? A Narrative Review. Open Access Emerg Med. 2020, Buonsenso D, Musolino A, Ferro V, et al. Role of lung ultrasound for the etiological diagnosis of acute lower respiratory tract infection (ALRTI) in children: a prospective study , J Ultrasound. 2021)

-please provide the explanation for the comparison method, as mention or" CXR either CT scan , there is mentioned that :"Reference standard diagnosis of positive or negative pneumonia was derived from chart data confirming a clinical diagnosis of pneumonia along with consistent findings on radiologic imaging"

-as pneumonia is not just an imaging diagnosis, maybe the change title should be considered because the study seemed to evaluated just the presence of consolidations

-the study declares that movies with consolidations were evaluated, no data on dimensions, and would be a significant bias, as they suggest etiology

-small consolidations < 1-1.5 cm are not visible on CXR(considered as gold standard) Berce V, Tomazin M, Gorenjak M, Berce T, Lovrenčič B. The usefulness of lung ultrasound for the aetiological diagnosis of community-acquired pneumonia in children. Sci Rep. 2019, therefore the US could be more sensitive in detecting small lesions, please comment on that, how was this considered in your study

-No data on pleural effusion

-No data on empiema or B lines, nor on atelectasis

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Thomas J. Marini

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Aug 27;19(8):e0309109. doi: 10.1371/journal.pone.0309109.r002

Author response to Decision Letter 0


29 Apr 2024

Response to Reviewers:

Re: PONE-D-23-38634, “Development and testing of a deep learning algorithm to detect pediatric pneumonia on a portable ultrasound device”

Reviewer #1:

1) I agree CXR is the current standard of care, but in meta-analysis lung ultrasound seems to perform better. Perhaps a distinction could be made in this regard:

We agree that recent meta-analysis comparing lung ultrasound (LUS) to CXR have demonstrated robust diagnostic accuracy in both pediatric and adult populations and have added additional comment and references in the revised Introduction.

2) The authors mention the use of adult imaging. I understand the focus of your manuscript is on pediatric patients. If possible, I still think the adults you scanned should ideally be included in the description of the study population section. Were adults enrolled with the same criteria?

Adults 18-80 years old with a clinical diagnosis of pneumonia and CXR and/or chest CT evidence of consolidation were enrolled separately, following provision of written informed consent. Adult patients were excluded if they were intubated, had active sepsis, cardiogenic pulmonary edema, known lung cancer, pulmonary embolus, chronic bronchiectasis or cystic fibrosis, or could not tolerate the LUS procedure. These details have been added to the Methods section of the revised manuscript.

3) Please consider explaining the rationale for adding adult images in a little more detail. You state it is to “enrich” the data but I think it may be beneficial to explain what about the adult data enriches the AI – for example more studies to train the AI, more generalizability etc.? …I think it could also be an interesting area of discussion in any differences between the adult and pediatric populations as a future consideration but I wouldn’t want this to distract from the focus of your manuscript which I feel is already well written as it is. Perhaps a few sentences could be included commenting on this in the discussion if you feel it could be beneficial. Otherwise, I also understand if you want to keep the focus of the manuscript on children and not comment further.

We added to the Results section of the revised manuscript additional detail regarding the rational for including in the training data set LUS data from 44 adults hospitalized with pneumonia as follows: “The addition of adult data served the dual purposes of increasing the amount of data (as deep learning networks require large amounts of training data) and adding more diversity. Specifically, the addition of adult data was felt to enhance representation of data from pediatric patients between 14-18 years old in the training data set.”

In our analysis, we did not specifically compare LUS imaging findings between pediatric and adult participants with consolidations. Thus, we feel that adding an additional discussion on age-based differences in identification of consolidations by LUS would not be appropriate for this manuscript.

4) If you had 117 unique exams, multiplied by 12 that would be 1,404 video clips. You report using 1,193 video clips. I assume the 211 difference related to clips that were not of adequate quality? What were some of the quality issues that made a clip not usable? For example, were their problems with motion artifact or not enough gel? If you could provide exact data regarding clips were rejected that would be interesting if you happened to record it, but I think even just some generalized qualitative description of things that affected quality would be helpful.

There were 117 unique exams, but the number of videos per exam was quite variable, ranging from 1 to 38. The average number of videos per exam was 10.2. Low quality videos were excluded, with the main issues compromising quality related to poor transducer contact, bad transducer angle, transducer motion, or other organs obstructing visualization of the lung. An explanation for exclusion of low quality videos is provided in the Results section of the revised manuscript.

5) Were the images acquired point-of-care at the bedside or in an ultrasound suite or a combination? Were the exams performed by physicians or by sonographers or a combination? Readers may also benefit from a little more information about how the people acquiring the images were trained and what their background was prior to the study. In the discussion you describe “minimally trained research personnel” line 306. I assume the multi-center nature of your study may have individuals with a variety of backgrounds acquiring the imaging? More information about those scanning and how many people scanned would be helpful/interesting if possible.

All images were acquired point-of-care at the bedside by clinicians or research staff members following training using a study-specific standardized operating procedure; images were not acquired by radiologists or professional sonographers. Prior experience with performance of lung ultrasonography ranged from none to moderate-level of experience. At one pediatric recruitment site, all images were acquired by a single clinician-researcher; at our second pediatric recruitment site, images were acquired by multiple clinician-researchers. Additional details regarding performance of the LUS procedure are included in the Methods section of the revised manuscript.

6) How many frames per second does Lumify record? Was every single frame labeled?

The Lumify was operated at 20 frames/second. Every frame of every video containing relevant lung features was annotated. These details are included in the Methods section of the revised manuscript.

7) My copy of Figure 1 and Figure 2 are grainy.

We apologize for the poor quality of the uploaded images. We have improved the quality of our figures for the revised manuscript.

Reviewer #2:

1) Please insert data to clarify the pneumonia diagnosis criteria used for this study

Following our approved IRB protocols and after receiving written informed consent and assent (if applicable), the medical records from each participant’s relevant hospitalization were reviewed to identify individuals diagnosed with pneumonia. Specifically, the following details have been added to the Methods section of the revised manuscript. “The medical records from each participant’s relevant hospitalization were reviewed to obtain demographic and clinical data and to identify individuals diagnosed with pneumonia. Specifically, data detailing admission and discharge diagnoses, results of any microbiologic testing (e.g., respiratory viral panel results were available for 77% of subjects), performance of pulmonary procedures (eg, chest tube placement; bronchoscopy), and images and clinical radiologists’ interpretation of chest imaging (available for 89% of subjects), were collected.”

2) Consolidations might be present even in viral pneumonia, please state the relation with etiology

We agree with the Reviewer that viral infections can be associated with focal pulmonary consolidations. While 77% of the subjects were tested for viral pathogens, our study was not designed or powered to examine correlations between identification of viral pathogens and focal lung consolidations, and we were unfortunately not able to probe this relationship in our data set. We have included this as a limitation in our revised manuscript.

3) No clear data on relation between dimensions and etiology, even if several paper suggests the relation

We appreciate the Reviewer’s reference to prior studies demonstrating the capacity of specific LUS findings to delineate different microbiologic (eg viral vs bacterial) causes of lower respiratory tract infection in children. As explained in our response above (Reviewer 2, #2), our study did not include comprehensive testing for causative pathogens and we are unfortunately unable to perform such an analysis with our current data set.

4) Please provide the explanation for the comparison method, as mentions either CXR or CT scan; there is mentioned that :"Reference standard diagnosis of positive or negative pneumonia was derived from chart data confirming a clinical diagnosis of pneumonia along with consistent findings on radiologic imaging"

The majority (i.e., 89%) of pediatric participants had CXRs/chest CTs obtained as part of their clinical care. We reviewed their interpretation to ensure that children with a clinical diagnosis of pneumonia had evidence of consolidation on routine clinical imaging.

5) As pneumonia is not just an imaging diagnosis, maybe the change title should be considered because the study seemed to evaluated just the presence of consolidations

We agree with the Reviewer that pneumonia is a clinical diagnosis that can be supported by findings of consolidation on lung imaging, and appreciate the suggestion to refine the title of this manuscript. We have retitle the revised manuscript “Development and testing of a deep learning algorithm to detect lung consolidation among children with pneumonia using hand-held ultrasound.”

6) The study declares that movies with consolidations were evaluated, no data on dimensions, and would be a significant bias, as they suggest etiology

As detailed above (Reviewer 2, #2 and #3 above), our study was not designed to identify or distinguish the etiology of pneumonia among participating children and this is now included as a study limitation in the revised manuscript.

7) Small consolidations < 1-1.5 cm are not visible on CXR (considered as gold standard) Berce V, Tomazin M, Gorenjak M, Berce T, Lovrenčič B. The usefulness of lung ultrasound for the aetiological diagnosis of community-acquired pneumonia in children. Sci Rep. 2019. Therefore, the US could be more sensitive in detecting small lesions, please comment on that, how was this considered in your study

We agree that US may be more sensitive than CXR for detection of small consolidations, and this was a consideration in regard to the algorithm’s false negative and false positive classifications. As discussed in the results section, a quarter of the consolidations missed by the algorithm were smaller in size, while over half of the false positives were triggered by abnormal pleural lines. Our study design, built for initial algorithm development and validation, did not allow us to examine the sensitivity of LUS for small consolidations less than 5 mm. We look forward to performing a study that examines the test characteristics of our LUS protocol and algorithm to address this important consideration. We have, however, added into the Discussion of the revised manuscript the potential for LUS (including the reference from Berce et al) to identify small consolidations.

8) No data on pleural effusion and no data on empyema or B lines, nor on atelectasis

The primary goal of this project was to develop an AI algorithm to detect lung consolidations, specifically, among children with a clinical diagnosis of pneumonia using a hand-held ultrasound devise. The dominant lung ultrasound features among this pediatric population were pleural lines, A-lines, B-lines, sub-pleural consolidations and consolidations of different sizes. In this cohort, pleural effusions were present in around 20% of the annotated videos; however, there were insufficient effusion data to allow development of the algorithm for detection of pleural effusions in children. The presence of empyema, B lines, and suspected atelectasis were not formally analyzed.

Attachment

Submitted filename: LUS_PONE_Response to Reviewers_Apr_29_24.docx

pone.0309109.s002.docx (22.1KB, docx)

Decision Letter 1

Tai-Heng Chen

23 Jun 2024

PONE-D-23-38634R1Development and testing of a deep learning algorithm to detect lung consolidation among children with pneumonia using hand-held ultrasoundPLOS ONE

Dear Dr. Kessler,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Aug 07 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Tai-Heng Chen, M.D., Ph.D.

Academic Editor

PLOS ONE

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thank you for your revisions and work on this manuscript. The original comments from the review have been addressed.

Reviewer #2: This is an interesting study on AI effect regarding lung consolidation detection in children pneumonia. Please provide data on pneumonia consolidation differentiation from atelectasis , as bronchogram exists in pneumonia and no in atelectasis. This issue must be addressed, in order not to create confusion.

Please provide diagnosis criteria for pneumonia used for the study; there is an addendum: "“The medical records from each participant’s relevant

hospitalization were reviewed to obtain demographic and clinical data and to identify

individuals diagnosed with pneumonia. Specifically, data detailing admission and

discharge diagnoses, results of any microbiologic testing.." but is not clear how did the patients were selected by protocol and criteria used. It looks like diagnosis was made randomly by other physicians, but what were the criteria used; were not established in the study design

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Thomas Marini

Reviewer #2: Yes: Ioana Ciuca

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Aug 27;19(8):e0309109. doi: 10.1371/journal.pone.0309109.r004

Author response to Decision Letter 1


16 Jul 2024

Response to Reviewers

PONE-D-23-38634R1

Development and testing of a deep learning algorithm to detect lung consolidation among children with pneumonia using hand-held ultrasound

Review Comments to the Author

Reviewer #1:

1. Thank you for your revisions and work on this manuscript. The original comments from the review have been addressed.

Thank you for the valuable feedback and helping to improve our manuscript.

Reviewer #2:

2. This is an interesting study on AI effect regarding lung consolidation detection in children pneumonia. Please provide data on pneumonia consolidation differentiation from atelectasis , as bronchogram exists in pneumonia and no in atelectasis. This issue must be addressed, in order not to create confusion.

We thank the reviewer for highlighting that consolidation due to pneumonia must be distinguished from atelectasis, and that the presence of dynamic air bronchograms supports a finding of consolidation resulting from pneumonia. For this study, all ultrasound images were reviewed and independently labelled by two physician experts in lung ultrasound. Reviewers separately annotated features of consolidation and atelectasis. The presence of air bronchograms was systematically used to distinguish consolidation resulting from suspected infection (pneumonia), from suspected atelectasis, and images annotated accordingly. For this study only videos that contained consolidation confirmed by two video annotators were included in the positive consolidation set. Suspected atelectasis was not included as a feature of consolidation reflecting pneumonia in training or testing of the model.

We have discussed this in the following sections of the manuscript:

Methods: (line 172) LUS images were annotated for atelectasis

“Labels included…atelectasis…”

Methods: (line 178):

“For this study, only videos that contained consolidation confirmed by two video annotators were included in the positive consolidation set. The presence of air bronchograms was routinely used to distinguish consolidation resulting from suspected infection (pneumonia) from suspected atelectasis with the latter feature deliberately excluded from model training.”

Results: (line 294) Some false positives were attributed to atelectasis

“…the remaining false positives were triggered by atelectasis…”

Limitations (line 362): “…it is not clear how well this algorithm will be able to distinguish pneumonia from other causes of consolidation artifacts on LUS (e.g. atelectasis)

3. Please provide diagnosis criteria for pneumonia used for the study; there is an addendum: "“The medical records from each participant’s relevant

hospitalization were reviewed to obtain demographic and clinical data and to identify

individuals diagnosed with pneumonia. Specifically, data detailing admission and

discharge diagnoses, results of any microbiologic testing.." but is not clear how did the patients were selected by protocol and criteria used. It looks like diagnosis was made randomly by other physicians, but what were the criteria used; were not established in the study design

To identify potentially eligible patients for study inclusion, emergency room and hospital ward censuses were reviewed by the study team to identify individuals being evaluated or admitted with suspected pneumonia who met study eligibility requirements, per approved IRB protocols. Following receipt of informed consent (and assent, if appropriate) from eligible participants, LUS was performed. Subsequently, data from the medical records from each participant’s relevant hospitalization were reviewed to obtain demographic and clinical data and to identify individuals diagnosed and treated for pneumonia. Specifically, data detailing admission and discharge diagnoses, results of any microbiologic testing (respiratory viral panel results were available for 77% of subjects), treatment course, performance of pulmonary procedures (eg, chest tube placement; bronchoscopy), and clinical radiologists’ interpretation of chest imaging (available for 89% of subjects), were collected.

Using this approach, participants with diagnostic studies, clinical course, and documentation supporting a diagnosis of pneumonia were systematically delineated from participants with other disease processes who were not diagnosed with pneumonia (see “Scanning protocol and imaging data” for further details).

As the reviewer notes, the diagnosis of pneumonia is a clinical diagnosis that can include signs such as fever, cough, pleuritic chest pain, and exam findings may include crackles on lung exam with varying degrees of respiratory distress (e.g. tachypnea and/or retractions).

Therefore, our primary definition for pneumonia relied upon our extensive chart review to confirm that a clinical diagnosis of pneumonia was made by treating physicians as evidenced by ICD diagnostic codes for admission and/or discharge diagnosis of pneumonia. We have included further details of this process outline above with edits to the methods in this revision of this manuscript.

Attachment

Submitted filename: PONED2338634 Response to Reviewers.docx

pone.0309109.s003.docx (17.7KB, docx)

Decision Letter 2

Tai-Heng Chen

6 Aug 2024

Development and testing of a deep learning algorithm to detect lung consolidation among children with pneumonia using hand-held ultrasound

PONE-D-23-38634R2

Dear Dr. Kessler,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Tai-Heng Chen, M.D., Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Thomas Marini

**********

Acceptance letter

Tai-Heng Chen

15 Aug 2024

PONE-D-23-38634R2

PLOS ONE

Dear Dr. Kessler,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Tai-Heng Chen

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Scanning zones for pediatric lung ultrasound.

    Lung image acquisition areas. Anterior scan areas: right hemithorax–areas 1, 2, 3, and 4; left hemithorax–areas 5, 6, 7, and 8. Posterior scan areas: right hemithorax–areas 9 and 10; left hemithorax–areas 11 and 12. (Created with BioRender.com).

    (PDF)

    pone.0309109.s001.pdf (338.8KB, pdf)
    Attachment

    Submitted filename: LUS_PONE_Response to Reviewers_Apr_29_24.docx

    pone.0309109.s002.docx (22.1KB, docx)
    Attachment

    Submitted filename: PONED2338634 Response to Reviewers.docx

    pone.0309109.s003.docx (17.7KB, docx)

    Data Availability Statement

    the data underlying the findings described within this manuscript are freely available in a public repository: (https://dataverse.harvard.edu/dataset.xhtml?persistentId=doi:10.7910/DVN/3HP1RD).


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES